Advertisement
Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates
(RTTNews) - Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.
Total revenues for the quarter soared to $12.39 million from $0.01 million in the same quarter last year, primarily due to SKYSONA and ZYNTEGLO product revenue. On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.67 per share on revenues of $13.41 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
798 วันที่ผ่านมา
Sensex Nifty Decline On Tariff Worries
Indian shares opened on a sluggish note on Thursday after U.S. President Donald Trump's 50 percent tariffs on Indian goods came into effect, impacting trade worth billions of dollars and risking Washington-New Delhi ties.
RTTNews
|
31 นาทีที่ผ่านมา
European Economic News Preview: Eurozone Economic Sentiment Data Due
Economic confidence and monetary aggregates from the euro area and flash GDP from Switzerland are the top economic news due on Thursday. At 3.00 am ET, the State Secretariat for Economic Affairs is slated to release Swiss GDP data for the second quarter. The economy is expected to grow 0.1 percent sequentially after rising 0.5 percent in the first quarter.
RTTNews
|
32 นาทีที่ผ่านมา
Australian Market Trims Early Losses In Mid-market
The Australian market is trimming early losses in mid-market moves on Thursday, giving up some of the gains in the previous session, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling to near the 8,950 level, with weakness in iron ore miners, energy and technology stocks partially offset by gains in financial stocks.
RTTNews
|
1 ชม. 58 นาทีที่ผ่านมา
Asian Markets Trade Mostly Higher
Asian stock markets are mostly higher on Thursday, following the broadly positive cues from Wall Street overnight, as traders remain optimistic the US Fed will cut interest rates at their next meeting in September. They also remain cautious ahead of the release of key US economic data later in the week, including second quarter GDP and the Fed's preferred readings on consumer price inflation.
RTTNews
|
2 ชม. 13 นาทีที่ผ่านมา
Sensex, Nifty Set To Open Lower As New U.S. Tariffs Take Effect
Indian shares may open on a weak note on Thursday after U.S. President Donald Trump's 50 percent tariffs on Indian goods came into effect on Wednesday.
RTTNews
|
2 ชม. 44 นาทีที่ผ่านมา
Swiss Market Settles Modestly Higher
The Switzerland market closed modestly higher on Wednesday after staying firm right through the day's session, thanks to fairly strong buying at several counters.
The benchmark SMI closed up by 46.23 points or 0.38% at 12,207.12. The index moved between 12,166.23 and 12,226.36 during the session.
RTTNews
|
2 ชม. 56 นาทีที่ผ่านมา
Japanese Market Notably Higher
The Japanese market is trading notably higher on Thursday after opening in the red, extending the gains in the previous session, following the broadly positive cues from Wall Street overnight. The Nikkei 225 is moving well above the 42,650 level, with gains in index heavyweights, automakers and financial stocks.
RTTNews
|
3 ชม. 4 นาทีที่ผ่านมา
